# 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer

> clinical trial · VERIFIED · 2026-07-10

Status: NOT_YET_RECRUITING · Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Condition: Thyroid Cancer

- Company: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Sector: Thyroid Cancer
- Primary source: https://clinicaltrials.gov/study/NCT06991738

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.